Dr. Berti et al reply
J Rheumatol. 2021 Sep 15:jrheum.210968. doi: 10.3899/jrheum.210968. Online ahead of print.ABSTRACTWe read with interest the comment of Dr. Kawada1 on our article that showed an inverse association between current smoking status and primary (p-) Sjögren syndrome (SS), and no association between obesity and pSS.2.PMID:34526391 | DOI:10.3899/jrheum.210968 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Alvise Berti Divi Cornec Cynthia S Crowson Eric L Matteson Source Type: research

Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept
J Rheumatol. 2021 Sep 15:jrheum.210540. doi: 10.3899/jrheum.210540. Online ahead of print.ABSTRACTActive tuberculosis (TB) in patients treated with anti-tumor necrosis factor-α (TNF-α) agents usually results from the reactivation of a latent infection.1,2 A 46-year-old woman with rheumatoid arthritis in Disease Activity Score in 28 joints remission who was taking etanercept (ETN) was admitted in our hospital due to a 4-month history of progressive hypoesthesia and paresthesia, initially on her left foot and later with extension up to the left knee.PMID:34526392 | DOI:10.3899/jrheum.210540 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Bruno Miguel Fernandes Jos é Miguel Pereira Pedro Rodrigues Pereira Miguel Bernardes Source Type: research

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Eric Toussirot Martin Michaud Daniel Wendling Val érie Devauchelle Source Type: research

Smoking, Obesity, and Risk of Primary Sj ögren Syndrome
J Rheumatol. 2021 Sep 15:jrheum.210808. doi: 10.3899/jrheum.210808. Online ahead of print.ABSTRACTI read the paper by Servioli et al1 conducting a 1:3 case-control study to evaluate the association between smoking status and primary (p-) Sjögren syndrome (SS). ORs (95% CIs) of current and former smokers compared to never smokers for pSS were 0.34 (0.14-0.85) and 1.27 (0.80-2.03), respectively. In contrast, there was no significant association of smoking status with antinuclear antibody, anti-SSA, anti-SSB, or rheumatoid factor positivity.PMID:34526394 | DOI:10.3899/jrheum.210808 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Tomoyuki Kawada Source Type: research

Is Psoriatic Arthritis Associated With Higher Risk of Mortality?
J Rheumatol. 2021 Sep 15:jrheum.210963. doi: 10.3899/jrheum.210963. Online ahead of print.ABSTRACTPsoriatic arthritis (PsA) is a systemic inflammatory disease affecting domains beyond the musculoskeletal system, and may lead to disability and impaired quality of life. It is associated with comorbidities such as hypertension, diabetes mellitus, obesity, metabolic syndrome, and increased risk of cardiovascular events.PMID:34526395 | DOI:10.3899/jrheum.210963 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Ying-Ying Leung Source Type: research

IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis
We describe a report of IgG4RD developing in a patient with AS.PMID:34526396 | DOI:10.3899/jrheum.201552 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Sophie Wojcik Robert D Inman Akihiro Nakamura Source Type: research

Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND
CONCLUSION: Oral baricitinib maintained lower levels of radiographic progression than initial csDMARD or placebo through 5 years in patients with active RA.PMID:34526397 | DOI:10.3899/jrheum.210346 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: D ésirée van der Heijde Cynthia E Kartman Li Xie Scott Beattie Douglas Schlichting Daojun Mo Patrick Durez Yoshiya Tanaka Roy Fleischmann Source Type: research

Dr. Berti et al reply
J Rheumatol. 2021 Sep 15:jrheum.210968. doi: 10.3899/jrheum.210968. Online ahead of print.ABSTRACTWe read with interest the comment of Dr. Kawada1 on our article that showed an inverse association between current smoking status and primary (p-) Sjögren syndrome (SS), and no association between obesity and pSS.2.PMID:34526391 | DOI:10.3899/jrheum.210968 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Alvise Berti Divi Cornec Cynthia S Crowson Eric L Matteson Source Type: research

Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept
J Rheumatol. 2021 Sep 15:jrheum.210540. doi: 10.3899/jrheum.210540. Online ahead of print.ABSTRACTActive tuberculosis (TB) in patients treated with anti-tumor necrosis factor-α (TNF-α) agents usually results from the reactivation of a latent infection.1,2 A 46-year-old woman with rheumatoid arthritis in Disease Activity Score in 28 joints remission who was taking etanercept (ETN) was admitted in our hospital due to a 4-month history of progressive hypoesthesia and paresthesia, initially on her left foot and later with extension up to the left knee.PMID:34526392 | DOI:10.3899/jrheum.210540 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Bruno Miguel Fernandes Jos é Miguel Pereira Pedro Rodrigues Pereira Miguel Bernardes Source Type: research

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Eric Toussirot Martin Michaud Daniel Wendling Val érie Devauchelle Source Type: research

Smoking, Obesity, and Risk of Primary Sj ögren Syndrome
J Rheumatol. 2021 Sep 15:jrheum.210808. doi: 10.3899/jrheum.210808. Online ahead of print.ABSTRACTI read the paper by Servioli et al1 conducting a 1:3 case-control study to evaluate the association between smoking status and primary (p-) Sjögren syndrome (SS). ORs (95% CIs) of current and former smokers compared to never smokers for pSS were 0.34 (0.14-0.85) and 1.27 (0.80-2.03), respectively. In contrast, there was no significant association of smoking status with antinuclear antibody, anti-SSA, anti-SSB, or rheumatoid factor positivity.PMID:34526394 | DOI:10.3899/jrheum.210808 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Tomoyuki Kawada Source Type: research

Is Psoriatic Arthritis Associated With Higher Risk of Mortality?
J Rheumatol. 2021 Sep 15:jrheum.210963. doi: 10.3899/jrheum.210963. Online ahead of print.ABSTRACTPsoriatic arthritis (PsA) is a systemic inflammatory disease affecting domains beyond the musculoskeletal system, and may lead to disability and impaired quality of life. It is associated with comorbidities such as hypertension, diabetes mellitus, obesity, metabolic syndrome, and increased risk of cardiovascular events.PMID:34526395 | DOI:10.3899/jrheum.210963 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Ying-Ying Leung Source Type: research

IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis
We describe a report of IgG4RD developing in a patient with AS.PMID:34526396 | DOI:10.3899/jrheum.201552 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Sophie Wojcik Robert D Inman Akihiro Nakamura Source Type: research

Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND
CONCLUSION: Oral baricitinib maintained lower levels of radiographic progression than initial csDMARD or placebo through 5 years in patients with active RA.PMID:34526397 | DOI:10.3899/jrheum.210346 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: D ésirée van der Heijde Cynthia E Kartman Li Xie Scott Beattie Douglas Schlichting Daojun Mo Patrick Durez Yoshiya Tanaka Roy Fleischmann Source Type: research

Dr. Berti et al reply
J Rheumatol. 2021 Sep 15:jrheum.210968. doi: 10.3899/jrheum.210968. Online ahead of print.ABSTRACTWe read with interest the comment of Dr. Kawada1 on our article that showed an inverse association between current smoking status and primary (p-) Sjögren syndrome (SS), and no association between obesity and pSS.2.PMID:34526391 | DOI:10.3899/jrheum.210968 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Alvise Berti Divi Cornec Cynthia S Crowson Eric L Matteson Source Type: research

Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept
J Rheumatol. 2021 Sep 15:jrheum.210540. doi: 10.3899/jrheum.210540. Online ahead of print.ABSTRACTActive tuberculosis (TB) in patients treated with anti-tumor necrosis factor-α (TNF-α) agents usually results from the reactivation of a latent infection.1,2 A 46-year-old woman with rheumatoid arthritis in Disease Activity Score in 28 joints remission who was taking etanercept (ETN) was admitted in our hospital due to a 4-month history of progressive hypoesthesia and paresthesia, initially on her left foot and later with extension up to the left knee.PMID:34526392 | DOI:10.3899/jrheum.210540 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Bruno Miguel Fernandes Jos é Miguel Pereira Pedro Rodrigues Pereira Miguel Bernardes Source Type: research

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Eric Toussirot Martin Michaud Daniel Wendling Val érie Devauchelle Source Type: research

Smoking, Obesity, and Risk of Primary Sj ögren Syndrome
J Rheumatol. 2021 Sep 15:jrheum.210808. doi: 10.3899/jrheum.210808. Online ahead of print.ABSTRACTI read the paper by Servioli et al1 conducting a 1:3 case-control study to evaluate the association between smoking status and primary (p-) Sjögren syndrome (SS). ORs (95% CIs) of current and former smokers compared to never smokers for pSS were 0.34 (0.14-0.85) and 1.27 (0.80-2.03), respectively. In contrast, there was no significant association of smoking status with antinuclear antibody, anti-SSA, anti-SSB, or rheumatoid factor positivity.PMID:34526394 | DOI:10.3899/jrheum.210808 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Tomoyuki Kawada Source Type: research

Is Psoriatic Arthritis Associated With Higher Risk of Mortality?
J Rheumatol. 2021 Sep 15:jrheum.210963. doi: 10.3899/jrheum.210963. Online ahead of print.ABSTRACTPsoriatic arthritis (PsA) is a systemic inflammatory disease affecting domains beyond the musculoskeletal system, and may lead to disability and impaired quality of life. It is associated with comorbidities such as hypertension, diabetes mellitus, obesity, metabolic syndrome, and increased risk of cardiovascular events.PMID:34526395 | DOI:10.3899/jrheum.210963 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Ying-Ying Leung Source Type: research

IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis
We describe a report of IgG4RD developing in a patient with AS.PMID:34526396 | DOI:10.3899/jrheum.201552 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Sophie Wojcik Robert D Inman Akihiro Nakamura Source Type: research

Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND
CONCLUSION: Oral baricitinib maintained lower levels of radiographic progression than initial csDMARD or placebo through 5 years in patients with active RA.PMID:34526397 | DOI:10.3899/jrheum.210346 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: D ésirée van der Heijde Cynthia E Kartman Li Xie Scott Beattie Douglas Schlichting Daojun Mo Patrick Durez Yoshiya Tanaka Roy Fleischmann Source Type: research

Dr. Berti et al reply
J Rheumatol. 2021 Sep 15:jrheum.210968. doi: 10.3899/jrheum.210968. Online ahead of print.ABSTRACTWe read with interest the comment of Dr. Kawada1 on our article that showed an inverse association between current smoking status and primary (p-) Sjögren syndrome (SS), and no association between obesity and pSS.2.PMID:34526391 | DOI:10.3899/jrheum.210968 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Alvise Berti Divi Cornec Cynthia S Crowson Eric L Matteson Source Type: research

Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept
J Rheumatol. 2021 Sep 15:jrheum.210540. doi: 10.3899/jrheum.210540. Online ahead of print.ABSTRACTActive tuberculosis (TB) in patients treated with anti-tumor necrosis factor-α (TNF-α) agents usually results from the reactivation of a latent infection.1,2 A 46-year-old woman with rheumatoid arthritis in Disease Activity Score in 28 joints remission who was taking etanercept (ETN) was admitted in our hospital due to a 4-month history of progressive hypoesthesia and paresthesia, initially on her left foot and later with extension up to the left knee.PMID:34526392 | DOI:10.3899/jrheum.210540 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Bruno Miguel Fernandes Jos é Miguel Pereira Pedro Rodrigues Pereira Miguel Bernardes Source Type: research

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Eric Toussirot Martin Michaud Daniel Wendling Val érie Devauchelle Source Type: research

Smoking, Obesity, and Risk of Primary Sj ögren Syndrome
J Rheumatol. 2021 Sep 15:jrheum.210808. doi: 10.3899/jrheum.210808. Online ahead of print.ABSTRACTI read the paper by Servioli et al1 conducting a 1:3 case-control study to evaluate the association between smoking status and primary (p-) Sjögren syndrome (SS). ORs (95% CIs) of current and former smokers compared to never smokers for pSS were 0.34 (0.14-0.85) and 1.27 (0.80-2.03), respectively. In contrast, there was no significant association of smoking status with antinuclear antibody, anti-SSA, anti-SSB, or rheumatoid factor positivity.PMID:34526394 | DOI:10.3899/jrheum.210808 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Tomoyuki Kawada Source Type: research

Is Psoriatic Arthritis Associated With Higher Risk of Mortality?
J Rheumatol. 2021 Sep 15:jrheum.210963. doi: 10.3899/jrheum.210963. Online ahead of print.ABSTRACTPsoriatic arthritis (PsA) is a systemic inflammatory disease affecting domains beyond the musculoskeletal system, and may lead to disability and impaired quality of life. It is associated with comorbidities such as hypertension, diabetes mellitus, obesity, metabolic syndrome, and increased risk of cardiovascular events.PMID:34526395 | DOI:10.3899/jrheum.210963 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Ying-Ying Leung Source Type: research

IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis
We describe a report of IgG4RD developing in a patient with AS.PMID:34526396 | DOI:10.3899/jrheum.201552 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Sophie Wojcik Robert D Inman Akihiro Nakamura Source Type: research

Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND
CONCLUSION: Oral baricitinib maintained lower levels of radiographic progression than initial csDMARD or placebo through 5 years in patients with active RA.PMID:34526397 | DOI:10.3899/jrheum.210346 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: D ésirée van der Heijde Cynthia E Kartman Li Xie Scott Beattie Douglas Schlichting Daojun Mo Patrick Durez Yoshiya Tanaka Roy Fleischmann Source Type: research

Dr. Berti et al reply
J Rheumatol. 2021 Sep 15:jrheum.210968. doi: 10.3899/jrheum.210968. Online ahead of print.ABSTRACTWe read with interest the comment of Dr. Kawada1 on our article that showed an inverse association between current smoking status and primary (p-) Sjögren syndrome (SS), and no association between obesity and pSS.2.PMID:34526391 | DOI:10.3899/jrheum.210968 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Alvise Berti Divi Cornec Cynthia S Crowson Eric L Matteson Source Type: research

Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept
J Rheumatol. 2021 Sep 15:jrheum.210540. doi: 10.3899/jrheum.210540. Online ahead of print.ABSTRACTActive tuberculosis (TB) in patients treated with anti-tumor necrosis factor-α (TNF-α) agents usually results from the reactivation of a latent infection.1,2 A 46-year-old woman with rheumatoid arthritis in Disease Activity Score in 28 joints remission who was taking etanercept (ETN) was admitted in our hospital due to a 4-month history of progressive hypoesthesia and paresthesia, initially on her left foot and later with extension up to the left knee.PMID:34526392 | DOI:10.3899/jrheum.210540 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Bruno Miguel Fernandes Jos é Miguel Pereira Pedro Rodrigues Pereira Miguel Bernardes Source Type: research

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
J Rheumatol. 2021 Sep 15:jrheum.210455. doi: 10.3899/jrheum.210455. Online ahead of print.ABSTRACTGlucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.PMID:34526393 | DOI:10.3899/jrheum.210455 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Eric Toussirot Martin Michaud Daniel Wendling Val érie Devauchelle Source Type: research

Smoking, Obesity, and Risk of Primary Sj ögren Syndrome
J Rheumatol. 2021 Sep 15:jrheum.210808. doi: 10.3899/jrheum.210808. Online ahead of print.ABSTRACTI read the paper by Servioli et al1 conducting a 1:3 case-control study to evaluate the association between smoking status and primary (p-) Sjögren syndrome (SS). ORs (95% CIs) of current and former smokers compared to never smokers for pSS were 0.34 (0.14-0.85) and 1.27 (0.80-2.03), respectively. In contrast, there was no significant association of smoking status with antinuclear antibody, anti-SSA, anti-SSB, or rheumatoid factor positivity.PMID:34526394 | DOI:10.3899/jrheum.210808 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Tomoyuki Kawada Source Type: research

Is Psoriatic Arthritis Associated With Higher Risk of Mortality?
J Rheumatol. 2021 Sep 15:jrheum.210963. doi: 10.3899/jrheum.210963. Online ahead of print.ABSTRACTPsoriatic arthritis (PsA) is a systemic inflammatory disease affecting domains beyond the musculoskeletal system, and may lead to disability and impaired quality of life. It is associated with comorbidities such as hypertension, diabetes mellitus, obesity, metabolic syndrome, and increased risk of cardiovascular events.PMID:34526395 | DOI:10.3899/jrheum.210963 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Ying-Ying Leung Source Type: research

IgG4-related Disease in a Patient With Ankylosing Spondylitis: Clues to Common Immunopathogenesis
We describe a report of IgG4RD developing in a patient with AS.PMID:34526396 | DOI:10.3899/jrheum.201552 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: Sophie Wojcik Robert D Inman Akihiro Nakamura Source Type: research

Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND
CONCLUSION: Oral baricitinib maintained lower levels of radiographic progression than initial csDMARD or placebo through 5 years in patients with active RA.PMID:34526397 | DOI:10.3899/jrheum.210346 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 16, 2021 Category: Rheumatology Authors: D ésirée van der Heijde Cynthia E Kartman Li Xie Scott Beattie Douglas Schlichting Daojun Mo Patrick Durez Yoshiya Tanaka Roy Fleischmann Source Type: research

Performance of three composite measures for disease activity in peripheral spondyloarthritis
CONCLUSION: The performance of DAPSA, PASDAS and ASDAS in pSpA was acceptable, and independent of concomitant psoriasis. Due to discrepancy in classification, the validity of existing thresholds for disease activity states warrants further study in pSpA.PMID:34470791 | DOI:10.3899/jrheum.210075 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Esther Beckers Marin Been Casper Webers Annelies Boonen Peter M Ten Klooster Harald E Vonkeman Astrid van Tubergen Source Type: research

Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020
J Rheumatol. 2021 Sep 1:jrheum.210537. doi: 10.3899/jrheum.210537. Online ahead of print.ABSTRACTRituximab (RTX) is the only biologic approved to date for the treatment of antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV).1,2,3 The Canadian Vasculitis Research Network (CanVasc) has recommended RTX as first-line therapy for remission induction,4 and recently, as the preferred maintenance agent in severe granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).5.PMID:34470792 | DOI:10.3899/jrheum.210537 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Arielle Mendel Christian Pagnoux Source Type: research

Lifestyle Factors and Disease Activity over Time in Early Axial Spondyloarthritis - The SPondyloArthritis Caught Early (SPACE) Cohort
J Rheumatol. 2021 Sep 1:jrheum.210046. doi: 10.3899/jrheum.210046. Online ahead of print.ABSTRACTOBJECTIVE: Our aim was to study the importance of baseline Body Mass Index (BMI), smoking and alcohol consumption (AC) for disease activity (DA) over one year in early axial spondyloarthritis (axSpA), stratified by sex.METHODS: In the SPondyloArthritis Caught Early cohort (patients with chronic back pain for ≥3 months, ≤2 years and onset
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Sofia Exarchou Carl Turesson Ulf Lindstr öm Roberta Ramonda Robert B M Landew é Hanne Dagfinrud Floris van Gaalen D ésirée van der Heijde Lennart T H Jacobsson Source Type: research

The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review
J Rheumatol. 2021 Sep 1:jrheum.210822. doi: 10.3899/jrheum.210822. Online ahead of print.ABSTRACTIn the management of rheumatoid arthritis (RA), the systematic evaluation of disease activity is of paramount importance. It is the cornerstone of the "treat-to-target" approach, aiming at disease remission and optimization of quality of life.1 In times of increasing delivery of remote care, accelerated due to the coronavirus disease 2019 (COVID-19) pandemic, the role of patients in the monitoring of disease activity becomes more topical.PMID:34470794 | DOI:10.3899/jrheum.210822 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Salima Francis Elisabeth van Weely Source Type: research

Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus
J Rheumatol. 2021 Sep 1:jrheum.201466. doi: 10.3899/jrheum.201466. Online ahead of print.ABSTRACTOBJECTIVE: Frailty is associated with mortality in systemic lupus erythematosus (SLE), but how best to measure frailty is unclear. We aimed to compare two frailty metrics, the self-reported FRAIL scale (FS) and the Fried phenotype (FP), in SLE to evaluate differences between frail and nonfrail women and whether frailty is associated with self-reported disability.METHODS: Adult women
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Sarah B Lieber Musarrat Nahid Stephen Paget Jessica R Berman Medha Barbhaiya Lisa R Sammaritano Kyriakos Kirou John A Carrino Mangala Rajan Dina Sheira Lisa A Mandl Source Type: research

Dr. Mease et al reply
J Rheumatol. 2021 Sep 1:jrheum.210750. doi: 10.3899/jrheum.210750. Online ahead of print.ABSTRACTWe thank Dr. Maguire et al1 for their interest in and appreciation of our study from the Corrona Psoriatic Arthritis/ Spondyloarthritis Registry comparing patient characteristics and disease burden between men and women with axial spondyloarthritis (axSpA).2 Dr. Maguire and colleagues raised a number of interesting questions around the causal relationship between the higher prevalence of depression and decreased work productivity we observed in women in our study.PMID:34470796 | DOI:10.3899/jrheum.210750 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Philip J Mease Robert R McLean Blessing Dube Mei Liu Sabrina Rebello Meghan Glynn Esther Yi Yujin Park Alexis Ogdie Source Type: research

Relationship of Patellofemoral Osteoarthritis to Changes in Performance-Based Physical Function Over 7 Years: The Multicenter Osteoarthritis Study
J Rheumatol. 2021 Sep 1:jrheum.210270. doi: 10.3899/jrheum.210270. Online ahead of print.ABSTRACTOBJECTIVE: Determine the relationship of patellofemoral osteoarthritis (OA) to changes in performancebased function over 7 years.METHODS: 2666 participants (62.2±8.0 years, BMI 30.6±5.9kg/m2; 60% female) from the Multicenter Osteoarthritis Study with knee radiographs at baseline and who completed repeated chair stands and 20- meter walk test at baseline, 2.5, 5, and 7 years were included. Generalized linear models assessed the relation of radiographic patellofemoral OA and radiographic patellofemoral OA with frequ...
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Harvi F Hart Tuhina Neogi Michael LaValley Daniel White Yuqing Zhang Michael C Nevitt James Torner Cora E Lewis Joshua J Stefanik Source Type: research

COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance
CONCLUSION: Women with rheumatic diseases who were pregnant at the time of COVID-19 had favourable outcomes. These data have limitations due to the small size and methodology, though they provide cautious optimism for pregnancy outcomes for women with rheumatic disease given the increased risk of poor outcomes that have been reported in other series of pregnant women with COVID-19.PMID:34470798 | DOI:10.3899/jrheum.210480 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Bonnie L Bermas Milena Gianfrancesco Helen L Tanner Andrea M Seet Mathia C Aguiar Nasra K Al Adhoubi Samar Al Emadi Bernardo M Cunha Rachael Flood Daria A Kusevich Eoghan M McCarthy Naomi J Patel Eric Ruderman Sebastian E Sattui Savino Sciascia Faizah Sid Source Type: research

What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout
CONCLUSION: Flare duration, flare frequency, and pain severity are all taken into account by patients with gout when considering treatment efficacy over time. Long-term studies of gout should ideally capture all these factors to better represent patients' experience of treatment success.PMID:34470799 | DOI:10.3899/jrheum.210476 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Jeremy Holyer Andrea Garcia-Guillen William J Taylor Angelo L Gaffo Merryn Gott Julia Slark Anne Horne Isabel Su Nicola Dalbeth Sarah Stewart Source Type: research

Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry
J Rheumatol. 2021 Sep 1:jrheum.210469. doi: 10.3899/jrheum.210469. Online ahead of print.ABSTRACTWe read with interest the recent article from Mease et al1 regarding the analysis of men and women with axial spondyloarthritis (axSpA) captured in the Corrona Psoriatic Arthritis/ Spondyloarthritis Registry. Dedicated comparative analysis in large, well-characterized cohorts such as this are crucial to identifying the variation of axSpA between males and females.PMID:34470800 | DOI:10.3899/jrheum.210469 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Sinead Maguire Gillian Fitzgerald Finbar O'Shea Source Type: research

Performance of three composite measures for disease activity in peripheral spondyloarthritis
CONCLUSION: The performance of DAPSA, PASDAS and ASDAS in pSpA was acceptable, and independent of concomitant psoriasis. Due to discrepancy in classification, the validity of existing thresholds for disease activity states warrants further study in pSpA.PMID:34470791 | DOI:10.3899/jrheum.210075 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Esther Beckers Marin Been Casper Webers Annelies Boonen Peter M Ten Klooster Harald E Vonkeman Astrid van Tubergen Source Type: research

Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020
J Rheumatol. 2021 Sep 1:jrheum.210537. doi: 10.3899/jrheum.210537. Online ahead of print.ABSTRACTRituximab (RTX) is the only biologic approved to date for the treatment of antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV).1,2,3 The Canadian Vasculitis Research Network (CanVasc) has recommended RTX as first-line therapy for remission induction,4 and recently, as the preferred maintenance agent in severe granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).5.PMID:34470792 | DOI:10.3899/jrheum.210537 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Arielle Mendel Christian Pagnoux Source Type: research

Lifestyle Factors and Disease Activity over Time in Early Axial Spondyloarthritis - The SPondyloArthritis Caught Early (SPACE) Cohort
J Rheumatol. 2021 Sep 1:jrheum.210046. doi: 10.3899/jrheum.210046. Online ahead of print.ABSTRACTOBJECTIVE: Our aim was to study the importance of baseline Body Mass Index (BMI), smoking and alcohol consumption (AC) for disease activity (DA) over one year in early axial spondyloarthritis (axSpA), stratified by sex.METHODS: In the SPondyloArthritis Caught Early cohort (patients with chronic back pain for ≥3 months, ≤2 years and onset
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Sofia Exarchou Carl Turesson Ulf Lindstr öm Roberta Ramonda Robert B M Landew é Hanne Dagfinrud Floris van Gaalen D ésirée van der Heijde Lennart T H Jacobsson Source Type: research

The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review
J Rheumatol. 2021 Sep 1:jrheum.210822. doi: 10.3899/jrheum.210822. Online ahead of print.ABSTRACTIn the management of rheumatoid arthritis (RA), the systematic evaluation of disease activity is of paramount importance. It is the cornerstone of the "treat-to-target" approach, aiming at disease remission and optimization of quality of life.1 In times of increasing delivery of remote care, accelerated due to the coronavirus disease 2019 (COVID-19) pandemic, the role of patients in the monitoring of disease activity becomes more topical.PMID:34470794 | DOI:10.3899/jrheum.210822 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Salima Francis Elisabeth van Weely Source Type: research

Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus
J Rheumatol. 2021 Sep 1:jrheum.201466. doi: 10.3899/jrheum.201466. Online ahead of print.ABSTRACTOBJECTIVE: Frailty is associated with mortality in systemic lupus erythematosus (SLE), but how best to measure frailty is unclear. We aimed to compare two frailty metrics, the self-reported FRAIL scale (FS) and the Fried phenotype (FP), in SLE to evaluate differences between frail and nonfrail women and whether frailty is associated with self-reported disability.METHODS: Adult women
Source: Journal of Rheumatology - September 2, 2021 Category: Rheumatology Authors: Sarah B Lieber Musarrat Nahid Stephen Paget Jessica R Berman Medha Barbhaiya Lisa R Sammaritano Kyriakos Kirou John A Carrino Mangala Rajan Dina Sheira Lisa A Mandl Source Type: research